report
Human microbiome drugs market to be valued at $2.13b by 2031
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024.
20 hours ago
Genomic biomarkers market to reach $50.31b by 2030
Thanks to rapid developments in next-generation sequencing and multi-omics.
3 days ago
India’s hospital sector poised for up to 12% CAGR over next 3-5 years
Healthcare expenditure increased by 9.8% YoY in the Union Budget FY26.
3 days ago
How will US tariffs affect Singapore’s biomedical sector?
Biomedical manufacturing output rose 89.6% in October 2025.
4 days ago
Vagus nerve stimulation market to be valued at $23.73b by 2031
Development in minimally invasive solutions drives the sector.
4 days ago
Cryopreservation freezer market to be valued at $840m by 2031
The expansion of biobanking activities serves as a key driver for market growth.
5 days ago
Next-generation sequencing services market to reach $8.77b by 2030
The growing use of precision medicine and genomics drives the sector.
6 days ago
Asia-Pacific to see fastest growth in SMRT sequencing through 2030
Thanks to rising public and private investment in genomics.
6 days ago
What lies ahead for Taiwan’s pacemakers market?
Adoption is also likely to accelerate across high-volume cardiac centres.
7MM age-related macular degeneration market to reach $20.5b by 2034
Its growth is supported by the anticipated launch of 26 new pipeline agents.
Respiratory CGT development remains limited as funding drops
However, R&D efforts on automation and AI are advancing manufacturing.
Respiratory inhaler devices market to hit $51.9b by 2034
Key drivers include developments in smart and sustainable designs.
India’s ultrasound systems market to reach $263m by 2034
The country accounted for 7% of the Asia Pacific market in 2025.
Breast cancer drugs market to be valued at $57.1b by 2031
By end user, hospitals accounted for about 46% of the total market value.
India’s cardiovascular monitoring devices market to reach $153m in 2036
The country represents 7% of the Asia-Pacific market in 2025.
What lies ahead for the cell and gene therapy market?
Major investors have committed over $3.5b across cumulative deals.
China medical device market grows at 8.1% CAGR through 2029
High costs remain a challenge despite expanding digital adoption.
Most Read
1. Radjak launches rapid cardiac, stroke unit for urban emergencies 2. Construction underway on Laos’ first national university hospital 3. Bayside Health begins operations in Victoria, Australia 4. How will US tariffs affect Singapore’s biomedical sector? 5. Northern Beaches Hospital to join NSW public health systemResource Center
Read Here
Advertise
Sign Up
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
